CT
Catinazzo Thomas Chief Financial Officer
CEO M
US US · SEC (Form 4)
€474,147
▼ Sales (11 ops.)
Browse the complete record of transactions filed by Catinazzo Thomas, Chief Financial Officer. Insider active across 2 companies, notably Relay Therapeutics, Inc.. In total, 22 filings have been published. Total volume traded: €474k. The latest transaction was disclosed on 14 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 22 total
US$194,469 17,717 shares @ US$10.9764 100.0% of flow
Common Stock
SEC:0001193125-26-224545 · 14 May 2026
€195,369 17,717 shares @ €11.0272 0.0084% mcap 24.1% of flow
Common Stock
SEC:0001193125-26-224545:0 · 14 May 2026
€5,758 300 shares @ €19.195 0.0002% mcap 0.7% of flow
Common Stock
SEC:0001209191-22-039659:0 · 27 Jun 2022
€17,648 725 shares @ €24.3426 0.0008% mcap 2.2% of flow
Common Stock
SEC:0001209191-22-026522:0 · 28 Apr 2022
€7,594 282 shares @ €26.9305 0.0003% mcap 0.9% of flow
Common Stock
SEC:0001209191-22-021828:0 · 29 Mar 2022
€49,734 13,286 shares @ €3.7433 0.0021% mcap 6.1% of flow
Common Stock
SEC:0001209191-22-021390:0 · 24 Mar 2022
039,270 shares 0
Common Stock
SEC:0001209191-22-005669:0 · 27 Jan 2022
039,270 shares 0
Common Stock
SEC:0001209191-22-005669 · 27 Jan 2022
€8,623 295 shares @ €29.2293 0.0006% mcap 2.5% of flow
Common Stock
SEC:0001209191-21-071314 · 27 Dec 2021
€8,623 295 shares @ €29.2293 0.0004% mcap 1.1% of flow
Common Stock
SEC:0001209191-21-071314:0 · 27 Dec 2021
€81,020 22,500 shares @ €3.6009 0.0055% mcap 23.7% of flow
Common Stock
SEC:0001209191-21-064892 · 15 Nov 2021
€81,020 22,500 shares @ €3.6009 0.0035% mcap 10.0% of flow
Common Stock
SEC:0001209191-21-064892:0 · 15 Nov 2021
€9,236 293 shares @ €31.5215 0.0006% mcap 2.7% of flow
Common Stock
SEC:0001209191-21-057862 · 27 Sept 2021
€9,236 293 shares @ €31.5215 0.0004% mcap 1.1% of flow
Common Stock
SEC:0001209191-21-057862:0 · 27 Sept 2021
€78,480 22,500 shares @ €3.488 0.0054% mcap 23.0% of flow
Common Stock
SEC:0001209191-21-055783 · 13 Sept 2021
€78,480 22,500 shares @ €3.488 0.0034% mcap 9.7% of flow
Common Stock
SEC:0001209191-21-055783:0 · 13 Sept 2021
€8,796 293 shares @ €30.0195 0.0006% mcap 2.6% of flow
Common Stock
SEC:0001209191-21-044063 · 28 Jun 2021
€8,796 293 shares @ €30.0195 0.0004% mcap 1.1% of flow
Common Stock
SEC:0001209191-21-044063:0 · 28 Jun 2021
€76,023 22,500 shares @ €3.3788 0.0052% mcap 22.3% of flow
Common Stock
SEC:0001209191-21-039325 · 7 Jun 2021
€79,071 22,500 shares @ €3.5143 0.0054% mcap 23.2% of flow
Common Stock
SEC:0001209191-21-039322 · 30 Mar 2021
€79,071 22,500 shares @ €3.5143 0.0034% mcap 9.7% of flow
Common Stock
SEC:0001209191-21-039322:0 · 30 Mar 2021
€76,023 22,500 shares @ €3.3788 0.0033% mcap 9.4% of flow
Common Stock
SEC:0001209191-21-039325:0 · 7 Jun 2021
About Catinazzo Thomas Catinazzo Thomas is the Chief Financial Officer of Relay Therapeutics, Inc.